Dr. Crescenzo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
531 W Germantown Pk
Suite 101
Plymouth Meeting, PA 19462Phone+1 610-539-5373Fax+1 877-593-1966- Is this information wrong?
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1996 - 1999
- Philadelphia College of Osteopathic MedicineInternship, Transitional Year, 1992 - 1993
- Philadelphia College of Osteopathic MedicineClass of 1992
- La Salle UniversityB.A., Biology, English, 1983 - 1987
Certifications & Licensure
- PA State License 1993 - 2020
- AOA Board of Internal Medicine Addiction Medicine (CAQ)
- American Osteopathic Bboard of Internal MedicineMedical Oncology
Awards, Honors, & Recognition
- Teacher of the Year PCOM, 2008, 2012
- Fellow ACOI
- Sigma Sigma Phi PCOM
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsEfficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias.Vamsi Kota, Tim H. Brümmendorf, Carlo Gambacorti-Passerini, Jeffrey H. Lipton, Dong-Wook Kim, Fiona An, Eric Leip, Rocco J. Crescenzo, Roxanne Ferdinand, Jorge E. Cortes> ;Leukemia Research. 2021 Aug 21
- 15 citationsPatient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia.Jorge E. Cortes, Carlo Gambacorti-Passerini, Michael W. Deininger, Michael J. Mauro, Charles Chuah, Dong-Wook Kim, Dragana Milojkovic, Philipp le Coutre, Valentín Garc...> ;Journal of Cancer Research and Clinical Oncology. 2019 Apr 15
- 10 citationsMatching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase...Jorge E. Cortes, B. Muresan, Carla Mamolo, Joseph C. Cappelleri, Rocco J. Crescenzo, Yun Su, Carlo Gambacorti-Passerini, Bart Heeg, B. Douglas Smith> ;Current Medical Research and Opinion. 2019 May 15
- Join now to see all
Journal Articles
- Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 TrialFloquet A, Vergote I, Colombo N, Fiane B, Monk BJ, Reinthaller A, Calvert P, Herzog TJ, Meier W, Kim JW, del Campo JM, Friedlander M, Pisano C, Isonishi S, Crescenzo R..., Gynecol Oncol, 1/1/2015
- An Immunological Analysis of Mesodermal Myogenic and Connective Tissue Precursors of the Chick EmbryoCrescenzo RJ, Journal of Cell Biology, 1/1/1990
- Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA31 (lapatinib vs trastuzumab)Crescenzo RJ, Breast Cancer Research
Books/Book Chapters
Abstracts/Posters
- Bosutinib vs. imatinib for newly diagnosed chronic myeloid leukemia (CML) in the BFORE trial: results by 3-month BCR-ABL1 transcript level.Crescenzo RJ, ESH-iCMLF, 1/1/2017
- Breast ultrasound and mammography and response to neoadjuvant lapatinib, trastuzumab and their combination in HER2 positive breast cancer: results from Neo-ALTTO (BIG ...Serena Di Cosimo, Christine Campbell , Hatem A. Azim Jr., Giuseppe Curigliano, Carmen Criscitiello, Rocco J Crescenzo, Martine J. Piccart-Gebhart, Holger Eidtmann, Jos..., SABC, 1/1/2015
- HLA-DRB1*7:01 Biomarker Characterization of Hepatotoxicity During Lapatinib Combination Therapies in ALTTOSpraggs C, Parham L, Liling W, Williams L, Briley LP, Fraser DJ, Aziz Z, Tong Z, Moodley S, Mehta AO, Jackson N, Byrne J, Andersson M, Toi M, Harris L, Gralow JR, Cres..., Abstract 617 ASCO, 1/1/2015
- Join now to see all
Lectures
- Infections in post-Bone Marrow Transplant PatientsHershey Lodge and Convention Centre, Hershey, PA, 2004, 2007, 2009, 2012 - 1/1/2012
- Use of TKI in Renal and Ovarian cancerMultiple Locations, 2008, 2009, 2011 - 1/1/2011
- Angiogenesis inhibitors in ovarian cancerHershey, PA - 1/1/2010
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: